Levodopa prodrugs, and compositions and uses thereof

Details for Australian Patent Application No. 2005252220 (hide)

Owner XenoPort, Inc.

Inventors Xiang, Jia-Ning; Jumbe, Nelson L.; Nguyen, Mark; Dai, Xuedong; Zhou, Cindy X.; Cundy, Kenneth C.; Li, Jianhua; Gallop, Mark A.

Agent Davies Collison Cave

Pub. Number AU-B-2005252220

PCT Pub. Number WO2005/121069

Priority 60/577,087 04.06.04 US

Filing date 3 June 2005

Wipo publication date 22 December 2005

Acceptance publication date 2 June 2011

International Classifications

C07C 229/36 (2006.01) Compounds containing amino and carboxyl groups bound to the same carbon skeleton

A61K 31/216 (2006.01)

A61K 31/24 (2006.01)

A61K 31/4409 (2006.01) - only substituted in position 4, e.g. isoniazid, iproniazid

A61K 31/455 (2006.01) - Nicotinic acid, i.e. niacin

A61K 31/609 (2006.01)

A61K 31/618 (2006.01)

A61P 25/16 (2006.01) Drugs for disorders of the nervous system

C07C 235/60 (2006.01) Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms

C07D 213/79 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/80 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

Event Publications

4 January 2007 PCT application entered the National Phase

  PCT publication WO2005/121069 Priority application(s): WO2005/121069

2 June 2011 Application Accepted

  Published as AU-B-2005252220

29 September 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005252222-Laminated material and skin contacting products formed therefrom

2005252217-Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis